DHR vs NTRA
Danaher Corporation and Natera, Inc., both Healthcare
Danaher Corporation is the larger company at $125B against $33B. Over the past year NTRA returned +140% against +11% for DHR. Ryufin's sector-relative Smart Score puts NTRA ahead, 10/10 against 6/10.
| Figure | DHR | NTRA |
|---|---|---|
| Last close | $215 | $339 |
| Market cap | $125B | $33B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 38.3 | n/a |
| 1-year return | +11% | +140% |
| 5-year return | -16% | +201% |
| Ryufin Smart Scoresector-relative, 1–10 | 6/10 | 10/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Danaher Corporation
Revenue of $6.3B in Q2 2026, net income $870M. Its largest reported line is Diagnostics, 46% of the disclosed total.
Natera, Inc.
Revenue of $753M in Q2 2026, net income null. Its largest reported line is US, 98% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.